Importantly, preventing calcium influx through genetic deletion of components of the calcium release-activated calcium channel (CRAC) pathway impairs CD8+ CTL effector function and antitumor immunity in mouse models for melanoma and colon carcinoma (132). The gene discussed is CD8A; the disease is melanoma.